EMMDELSA Trademark

Trademark Overview

On Wednesday, March 22, 2023, a trademark application was filed for EMMDELSA with the United States Patent and Trademark Office. The USPTO has given the EMMDELSA trademark a serial number of 97852368. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, January 14, 2025. This trademark is owned by Rain Oncology Inc.. The EMMDELSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for oncology treatment; pharmaceuticals for the treatment of liposarcoma; pharmaceuticals for the treatment of MDM2- amplified advanced solid tumors
emmdelsa

General Information

Serial Number97852368
Word MarkEMMDELSA
Filing DateWednesday, March 22, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, January 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for oncology treatment; pharmaceuticals for the treatment of liposarcoma; pharmaceuticals for the treatment of MDM2- amplified advanced solid tumors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRain Oncology Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60654
Party NameRain Oncology Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60654

Trademark Events

Event DateEvent Description
Saturday, March 25, 2023NEW APPLICATION ENTERED
Thursday, April 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 2, 2023ASSIGNED TO EXAMINER
Monday, June 12, 2023NON-FINAL ACTION WRITTEN
Monday, June 12, 2023NON-FINAL ACTION E-MAILED
Monday, June 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 5, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, September 5, 2023SUSPENSION LETTER WRITTEN
Tuesday, September 5, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 6, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, May 6, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, August 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 4, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, November 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 8, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, April 5, 2024SUSPENSION INQUIRY WRITTEN
Friday, April 5, 2024INQUIRY TO SUSPENSION E-MAILED
Friday, April 5, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

emmdelsa treatment pharmaceuticals pharmaceutical cancer preparations solid tumors advanced oncology liposarcoma